Postpartum hemorrhage (PPH) is one of the major causes of maternal mortality and
morbidity worldwide, with uterine atony being the most common origin. Currently there are …

Objective Postpartum hemorrhage (PPH) is a preventable condition and the main cause of
maternal death worldwide. Evidence on the effectiveness of misoprostol in the prevention of …

Background: Cooling the uterus during cesarean section has emerged as one of the non-
pharmacological management for blood loss during cesarean section. The aim of this study …

Objective The objective of this research is to create Innovation in midwifery practices as an
alternative to estimate postpartum blood loss. Methods This research is DRM (Design …

Background: To evaluate the effect of adjunctive misoprostol in preventing postpartum
haemorrhage (PPH) by selective administration above threshold bleeding in order to reduce …

Background The abortion rate is roughly 15–20%, and it is the most common complication of
early pregnancy in humans. Over the past decade, medical termination of pregnancy in the …

This systematic literature review was organized to evaluate a potential uterotonic agent
named misoprostol, as the choice to prevent and manage PPH. Compiled this systematic …

Objective: This randomised comparative clinical trial aimed to assess the effectiveness and
tolerability of combining oxytocin and misoprostol for preventing immediate postpartum …

Background: Long term exposure to oxytocin reduces the ability of myometrium to respond
to oxytocin, leading to oxytocin receptor (OXTR) desensitization. In this study we analyzed …

Background: Postpartum hemorrhage is one of the most common obstetrical complications
affecting up to 18% of deliveries. Globally, it is responsible for 35–55% of peripartum …